The genus Mycobacterium includes major human pathogens, such as the slowly growing species Mycobacterium tuberculosis, as well as rapidly growing species ubiquitous in the environment, such as Mycobacterium fortuitum, which may be opportunistic in compromised hosts. The mechanisms of resistance to antimicrobial agents found in mycobacteria are not very different from those found in other bacteria (9, 20) . In fastgrowing mycobacteria, several antibiotic resistance genes have been described. The gene sul3 was detected in one strain of M. fortuitum. This gene encodes resistance to sulfonamide and is highly related to other sul genes from gram-negative bacteria (19) . Tetracycline resistance determinants similar to those found in Streptomyces spp. and gram-positive bacteria have also been described (21) . In M. fortuitum, ␤-lactamases have been described as universally present, and the gene encoding a class A ␤-lactamase conferring resistance to ␤-lactam antibiotics has been cloned (31) .
Bacterial resistance to aminoglycosides is frequently mediated through aminoglycoside-modifying enzymes. These enzymes are frequently plasmid encoded, but in some cases, chromosomally encoded genes have been described (29) . The chromosomally encoded acetyltransferase aac(6Ј)-Ic (28) and aac(2Ј)-Ia (24) genes are widely spread in Serratia marcescens and Providencia stuartii species, respectively. In the antibiotic producers Streptomyces species, which along with mycobacteria belong to the order Actinomycetales, several chromosomally located aminoglycoside acetyltransferase (AAC) genes have been characterized (11, 13, 16) . The function of the chromosomal AAC enzymes remains unknown. Since they are not related to the biosynthesis of and resistance to aminoglycosides, it has been suggested that they may play a role in other metabolic processes.
The aac(2Ј)-Ia gene is the most studied chromosomal aac gene. This gene is universally present in P. stuartii and is normally expressed at low levels. Since it is not inducible by aminoglycosides, most strains are aminoglycoside susceptible. The culturing of P. stuartii in the presence of aminoglycosides allows for the isolation of mutants with an increased level of aac(2Ј)-Ia expression, which confers resistance to clinically important aminoglycosides such as gentamicin and tobramycin (24) . The expression of the aac(2Ј)-Ia gene is regulated at the transcriptional level by several trans-acting regulatory factors (18, 23, 24) . Recently, Payie et al. (22) have demonstrated that the AAC(2Ј)-Ia enzyme contributes to the O acetylation of peptidoglycan in P. stuartii, being essential for the maintenance of peptidoglycan structure (22) .
Aminoglycoside-modifying enzymes have also been described in mycobacteria. AACs are universally present in fastgrowing mycobacteria without any correlation between aminoglycoside resistance and AAC activity. In these strains, a relationship between the presence of plasmids and the production of AAC enzymes was not found (12, 32) , indicating that these enzymes could be chromosomally encoded. Single-step mutational frequencies are relatively high (10 Ϫ4 to 10
Ϫ5
) for resistance to a single aminoglycoside, and mutants showed cross-resistance to 2-deoxy-streptamine aminoglycosides (35) . In M. fortuitum, AAC(3) activity has been widely reported (34) , but the genes which code for these enzymes were not studied further at the molecular level.
The aim of the work described here was to characterize the genetic determinants of AAC activity in M. fortuitum as well as determine the relatedness between the presence of these genes and the level of resistance to aminoglycosides. As a result, we present the characterization of a chromosomal AAC gene aac(2Ј)-Ib, which encodes a protein similar to the AAC(2Ј)-Ia enzyme from P. stuartii.
(Some of the results of this work were presented at the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, Calif., 17 to 20 September 1995 [2] ).
MATERIALS AND METHODS
Bacterial strains, plasmids, and growth conditions. The reference strains and plasmids used in the study are listed in Table 1 . Thirty-four clinical and environmental M. fortuitum complex isolates (including strain FC1K) were obtained from the University of Zaragoza culture collection.
Middlebrook 7H9 broth and Middlebrook 7H10 agar (Difco Laboratories, Detroit, Mich.) were used to culture the mycobacterial strains. Escherichia coli XL1 was cultured in brain heart infusion (Difco). All the cultures were incubated at 37ЊC. Kanamycin A (20 g/ml; Sigma Chemical Co., St. Louis, Mo.) was added when necessary.
Antibiotic susceptibility testing. The MICs of the aminoglycosides were determined on Mueller-Hinton agar (Difco) by twofold dilution of antibiotics in a range of concentrations from 0.25 to 64 g/ml. The bacterial inoculum was adjusted to 10 Ϫ5 CFU/ml, and the plates were incubated at 37ЊC for up to 5 days. Assay for aminoglycoside-modifying enzymes. Cell-free mycobacterial extracts were obtained by ultrasonic disruption. The aminoglycoside-modifying enzymes were detected by the phosphocellulose paper-binding technique described previously (4). Quantitation of proteins in crude extracts was carried out as described previously (17) .
Genetic techniques. Both E. coli XL1 and Mycobacterium smegmatis mc 2 155 were transformed by electroporation. Briefly, competent cells were prepared by culturing the strains to an optical density of 0.75 and washing three times with 10% glycerol. Aliquots were snap frozen in a dry ice-ethanol bath and were stored at Ϫ80ЊC. Electroporation was performed with the Bio-Rad Gene Pulser (Bio-Rad Laboratories, Richmond, Calif.) at 2.5 kV. Plates containing 20 g of kanamycin per ml or 4 g of gentamicin per ml were used to select the transformants.
DNA techniques. (i) Preparation and analysis of DNA. Plasmid DNA from E. coli XL1 was extracted as described previously (26) . Mycobacterial DNA was extracted as follows: a saturated culture of M. fortuitum was incubated for 14 h with 1 mg of cycloserine (Sigma) per ml. The cells were pelleted and incubated for 1 h in 10 mM Tris-1 mM EDTA-25% sucrose-4 mg of lysozyme (Sigma) per ml at 37ЊC. Cells were lysed after the addition of 300 l of 1% sodium dodecyl sulfate (SDS) and 400 g of proteinase K (Sigma) per ml and incubation at 55ЊC for 1 h. This was followed by the addition of 120 l of 5 M NaCl. Following three phenol-chloroform extractions, DNA was precipitated with 98% ethanol.
(ii) Molecular biology procedures. Electrophoresis, digestions, ligations, and dephosphorylations were performed as described elsewhere (26) and according to the supplier's recommendations (Boehringer Mannheim GmbH, Mannheim, Germany).
Hybridizations. Gentamicin resistance gene probes were obtained as follows: For dot blot and Southern blot hybridizations, DNA from the Mycobacterium strains was transferred onto nylon filters (Hybond; Amersham International plc, Buckinghamshire, England) as described previously (26) . The probes were labelled by random primer labelling (Rediprime; Amersham) with [␣-32 P]dCTP (Redivue; Amersham). Prehybridizations and hybridizations were carried out in Rapid Hybridization Buffer (Amersham) at 65ЊC for 30 min and 4 h, respectively. Filters were washed at 65ЊC twice with 2ϫ SSC (1ϫ SSC is 0.15 M NaCl plus 0.015 M sodium citrate)-0.1% SDS, once with 1ϫ SSC-0.1% SDS, and once with 0.7ϫ SSC-0.1% SDS. When low-stringency conditions were desired, the filters were washed at 42ЊC. Autoradiography was carried out by exposing X-ray film (X-Omat; Eastman Kodak Co., Rochester, N.Y.) to the filters for 18 h at Ϫ80ЊC.
DNA sequencing. Double-stranded DNA sequencing was performed by the dideoxynucleotide chain termination method with the fmol DNA Sequencing System (Promega Corporation, Madison, Wis.) with M13 universal primers (Promega) according to the manufacturer's instructions.
Computer analysis of sequence data. Nucleotide and amino acid sequences were analyzed and compared by using the Genetics Computer Group software (7) at Centro Nacional de Biotecnología, Madrid, Spain. Databases were searched with the program Blastncbi at the National Center for Biological Information.
Nucleotide sequence accession number. The nucleotide sequence of the aac(2Ј)-Ib gene has been deposited in the GenBank data library under the accession number U41471.
RESULTS
Presence of AAC enzymes in M. fortuitum and resistance to gentamicin. Thirty-four environmental and clinical isolates belonging to the M. fortuitum complex were chosen for the present study. The MICs of gentamicin varied, ranging from 2 to 16 g/ml. Crude extracts of all 34 strains were shown to have AAC activity. Acetylation of gentamicin, tobramycin, and kanamycins A and B was found for all the strains, showing a substrate profile consistent with the presence of an AAC(3) activity.
Environmental isolate M. fortuitum FC1K was chosen for further studies because of its high level of AAC activity and the level of resistance to gentamicin (MIC, 16 g/ml).
Isolation and characterization of the gentamicin resistance determinant from M. fortuitum FC1K. In order to clone the genetic determinant of gentamicin resistance in M. fortuitum, we took two different approaches: hybridization with aac (3) probes from different organisms and construction of M. fortuitum genomic libraries in different hosts (E. coli, Streptomyces lividans, and M. smegmatis).
No hybridization was detected between total DNA of M. fortuitum FC1K and probes specific for the aac (3) select 80 clones of M. smegmatis resistant to 4 g of gentamicin per ml (1) . Four of these clones were analyzed and were shown to carry different recombinant plasmids, namely, pAC19, pAC20, pAC21, and pAC23, that conferred gentamicin resistance to M. smegmatis. Restriction maps showed that the four plasmids shared a common region (Fig. 1) . Plasmid pAC20 was chosen for further studies because it carried the smallest insert. The 1.7-kb PvuII-PvuII fragment from pAC20 was cloned into the Klenow fragment-treated BamHI site of pSUM36, resulting in pAC100. M. smegmatis mc 2 155 harboring either pAC20 or pAC100 gave an AAC(2Ј) resistance profile, and the MICs of gentamicin, tobramycin, dibekacin, netilmicin, and 6Ј-Nethylnetilmicin for these strains were greater than those for M. smegmatis mc 2 155 (Table 2) . Inactivation of cloned aac(2)-Ib gene by mutation. A 1.4-kb HindIII-EcoRV fragment was deleted from plasmid pAC20, resulting in plasmid pAC63, in which the unique BamHI site is located inside the gene aac(2Ј)-Ib. Plasmid pAC63 was digested with BamHI, blunt ended with the Klenow fragment, and religated to produce plasmid pAC63* (Fig. 1) . Both plasmids pAC63 and pAC63* were electroporated in M. smegmatis mc 2 155, and the level of resistance to aminoglycosides was studied by determination of the MICs ( 2 155/pAC100 were shown to efficiently acetylate gentamicin C1 and C1a, tobramycin, netilmicin, and 6Ј-N-ethylnetilmicin as well as other aminoglycosides. However, 2Ј-Nethylnetilmicin, kanamycin A, and amikacin were poorly acetylated. Because these aminoglycosides lack the amino group at the 2Ј position, this confirmed the presence of 2Ј-Nacetyltransferase activity within pAC100. The substrate profile of the crude extract of M. smegmatis mc 2 155/pAC100 is shown in Table 3 .
Some AAC(2Ј) activity was observed in crude extracts from M. smegmatis mc 2 155. However, the determination of enzymatic activity showed a 20-fold increase of specific activity in the extract from M. smegmatis mc 2 155/pAC100 (45.3 U/g of protein) with respect to that in the extract from M. smegmatis mc 2 155 (2.19 U/g of protein).
Analysis of the deduced AAC(2)-Ib protein.
The sequences of the AAC(2Ј)-Ia enzyme from P. stuartii and the AAC(2Ј)-Ib protein from M. fortuitum were compared by using the program Pileup, and the alignment is presented in Fig. 3 . The enzymes have a similar size (178 and 195 amino acids, respectively), and the comparison of the deduced protein sequences showed 38% identity and 63% amino acid similarity, indicating that both enzymes belong to the same family of AACs. Filters containing DNA from different fast-growing mycobacteria (M. smegmatis, M. chelonae, and M. aurum) were also hybridized, but no hybridization was observed when the filters were washed under high-stringency conditions. However, when the washing conditions were less stringent, all the species hybridized in different bands (data not shown), suggesting that other fast-growing mycobacterial species may have genes homologous to aac(2Ј)-Ib.
The findings presented above and the negative results from different attempts to isolate plasmid DNA from M. fortuitum FC1K lead us to suspect that the gene aac(2Ј)-Ib could be chromosomally encoded.
DISCUSSION
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M. FORTUITUM aac(2Ј)-Ib GENE CHARACTERIZATION 2353 mycobacteria, we decided to study the genes responsible for the AAC activity in M. fortuitum. The substrate profile observed in the crude enzymatic extracts of all the strains of M. fortuitum tested was consistent with the presence of an AAC(3) enzyme; i.e., gentamicin, tobramycin, and kanamycins A and B were extensively acetylated (34) . This led us to use the probes derived from the aac (3) The changes in the MICs observed for M. smegmatis harboring plasmids pAC20 or pAC100 with respect to that for the control strain were characteristic of an AAC(2Ј) resistance profile, that is, an increase in the MICs of gentamicin, tobramycin, dibekacin, netilmicin, and 6Ј-N-ethylnetilmicin, whereas there was no increase in the MIC of 2Ј-N-ethylnetilmicin was seen. The MICs of kanamycin A and amikacin were not studied because of the presence of the enzyme APH(3Ј)-II from Tn5 as a selectable marker in those plasmids.
Moreover, the substrate profile of pAC100 showed that gentamicin, tobramycin, dibekacin, netilmicin, 6Ј-ethylnetilmicin, sisomicin, and 5Ј-episisomicin were acetylated, whereas kanamycin A, amikacin, and 2Ј-N-ethylnetilmicin were not. Because the latter aminoglycosides lack the 2Ј amino group, this substrate profile shows that this 2Ј amino group would be the site of acetylation, confirming the presence of AAC(2Ј) activity. However, because this substrate profile does not explain the acetylation of kanamycin A found in crude extracts of M. fortuitum FC1K, we suppose that there is another AAC capable of modifying kanamycin A, such as AAC (3) enzymes. The simultaneous presence of both AAC(2Ј) and AAC(3) enzymes has been described in some Streptomyces species (11) .
No plasmid could be detected in M. fortuitum FC1K even when other M. fortuitum plasmids were successfully isolated in our laboratory (8 (25) . These genes share three main characteristics: they are chromosomally encoded, they are species specific, and they are present in all strains of one bacterial species, which confers taxonomic importance on the chromosomally located aac genes.
We have studied the presence of the aac(2Ј)-Ib gene in other M. fortuitum strains by hybridization. We have demonstrated that the aac(2Ј)-Ib gene is universally present in all the M. fortuitum strains tested, but its presence is independent of the level of resistance to aminoglycosides. This suggests that the product of this gene could be implicated in functions other than aminoglycoside modification. In general, bacterial acetyltransferases are involved in a variety of cellular processes including acetylation of intermediate metabolites, ribosomal proteins, and cell wall components. Recently, the enzyme AAC(2Ј)-Ia has been shown to contribute to the acetylation of peptidoglycan in P. stuartii (18) . This strongly supports the hypothesis that aminoglycoside-modifying enzymes may be derived from genes implicated in diverse cellular processes. Other studies (33) have indicated that mycobacterial AACs are inhibited by some amino sugars and derivatives of coenzyme A other than acetyl coenzyme A. These findings indicate that these enzymes are capable of acetylating aminoglycosides and other molecules by using different derivatives of coenzyme A, suggesting that they are probably implicated in other metabolic processes such as biosynthesis of the cell wall. If this hypothesis is confirmed, it would open the possibility of discovery of new molecules that interfere in cell wall synthesis and that could be used as antimycobacterial agents.
Hybridization with aac(2Ј)-Ib as a probe under low-stringency conditions showed a signal in other fast-growing mycobacterial strains such as M. chelonae, M. aurum, and M. smegmatis (data not shown). This suggests that genes homologous to aac(2Ј)-Ib could be present in other fast-growing species. Indeed, the presence of AAC(2Ј) activity was previously detected in one strain of M. aurum (27) , and we have also detected this activity in M. smegmatis mc 2 155 in the course of the present work. We propose to extend the study to other fastgrowing and slowly growing mycobacterial species and to determine whether these genes could be implicated in functions other than aminoglycoside resistance.
Other characteristics of the chromosomally located AAC genes are that they have unusual transcription signals and are regulated. In this way, genes aac(2Ј)-Ia and aac(6Ј)-Ic from P. stuartii and S. marcescens, respectively, have the sequence CTT TTTT at the Ϫ35 region (24, 28) ; further determination of the 5Ј terminus of the aac(2Ј)-Ib mRNA will allow us to observe if such a sequence is also present in M. fortuitum. In P. stuartii, the expression of the aac(2Ј)-Ia gene is controlled at the transcriptional level by several trans-acting regulatory factors coded by the aarA, aarB, and aarC genes (23, 24) and a transcriptional activator coded by aarP which increased the level of aac(2Ј)-Ia expression (18) . Such a complex regulatory process may indicate that this gene has an important role in secondary 
